GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BSP:BMYB34) » Definitions » Cyclically Adjusted Price-to-FCF

Bristol-Myers Squibb Co (BSP:BMYB34) Cyclically Adjusted Price-to-FCF : 9.30 (As of Jun. 07, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF?

As of today (2025-06-07), Bristol-Myers Squibb Co's current share price is R$271.09. Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was R$29.16. Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF for today is 9.30.

The historical rank and industry rank for Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BSP:BMYB34' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 8.6   Med: 20.5   Max: 40.86
Current: 9.37

During the past years, Bristol-Myers Squibb Co's highest Cyclically Adjusted Price-to-FCF was 40.86. The lowest was 8.60. And the median was 20.50.

BSP:BMYB34's Cyclically Adjusted Price-to-FCF is ranked better than
91.41% of 326 companies
in the Drug Manufacturers industry
Industry Median: 31.405 vs BSP:BMYB34: 9.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted free cash flow per share data for the three months ended in Mar. 2025 was R$4.781. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is R$29.16 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.69 17.41 18.54 11.69 11.32

Bristol-Myers Squibb Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.91 9.01 10.73 11.32 11.95

Competitive Comparison of Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=271.09/29.16
=9.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Bristol-Myers Squibb Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=4.781/134.9266*134.9266
=4.781

Current CPI (Mar. 2025) = 134.9266.

Bristol-Myers Squibb Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.175 100.684 -0.235
201509 0.675 100.392 0.907
201512 1.380 99.792 1.866
201603 -1.035 100.470 -1.390
201606 0.363 101.688 0.482
201609 2.060 101.861 2.729
201612 2.136 101.863 2.829
201703 1.067 102.862 1.400
201706 2.668 103.349 3.483
201709 2.763 104.136 3.580
201712 1.731 104.011 2.246
201803 1.871 105.290 2.398
201806 1.980 106.317 2.513
201809 2.650 106.507 3.357
201812 7.745 105.998 9.859
201903 2.783 107.251 3.501
201906 4.456 108.070 5.563
201909 5.965 108.329 7.430
201912 4.083 108.420 5.081
202003 8.117 108.902 10.057
202006 10.001 108.767 12.406
202009 4.985 109.815 6.125
202012 7.018 109.897 8.616
202103 9.083 111.754 10.966
202106 6.364 114.631 7.491
202109 11.758 115.734 13.708
202112 9.515 117.630 10.914
202203 8.184 121.301 9.103
202206 4.672 125.017 5.042
202209 8.398 125.227 9.049
202212 7.317 125.222 7.884
202303 6.636 127.348 7.031
202306 3.759 128.729 3.940
202309 10.550 129.860 10.962
202312 9.453 129.419 9.855
202403 6.277 131.776 6.427
202406 5.479 132.554 5.577
202409 14.361 133.029 14.566
202412 12.205 133.157 12.367
202503 4.781 134.927 4.781

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bristol-Myers Squibb Co  (BSP:BMYB34) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co Business Description

Address
Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co Headlines

No Headlines